§ BIOTECHNOLOGY
USD · Biotechnology

SRPT

SAREPTA THERAPEUTICS INC
USDSector · BiotechnologyBeta · 0.30
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
156 increased/new, 122 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B1.98EPS (TTM)-7.24
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.14.8M0.0%+3%
VANGUARD PORTFOLIO MANAGEMENT LLC6.6Mn/an/a
State Street6.6M0.0%+0%
AQR Capital Management6.4M0.1%−17%
TWO SIGMA INVESTMENTS, LP4.6M0.1%+88%
VANGUARD CAPITAL MANAGEMENT LLC4.6Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for SRPT as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER51.9% · 239 holders
PASSIVE / INDEX22.1% · 8 holders
DEALER / BANK18.9% · 34 holders
QUALITY / COMPOUNDER6.7% · 21 holders
SYSTEMATIC / QUANT5.0% · 11 holders
TACTICAL / MACRO4.7% · 6 holders
INCOME / DEFENSIVE2.0% · 24 holders
ACTIVIST0.6% · 1 holder
GROWTH / MOMENTUM0.2% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for SRPT in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention SRPT yet.